XML 59 R44.htm IDEA: XBRL DOCUMENT
v3.23.3

Revenue from Contracts with Customers (Tables) | 12 Months Ended
--- | ---
Sep. 30, 2023
Revenue from Contract with Customer [Abstract] |
Schedule of disaggregated revenue by significant business line | The Company disaggregates revenue from contracts with customers in a manner that depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. The following is revenue by significant business line for the fiscal years ended September 30, 2023, 2022 and 2021 (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​
​ | ​ | ​ | 2023 | ​ | 2022 | ​ | 2021
Significant Business Line | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Life Sciences Products, excluding B Medical | ​ | $ | 192,061 | ​ | $ | 199,230 | ​ | $ | 199,606
B Medical | ​ | ​ | 113,122 | ​ | ​ | - | ​ | ​ | -
Sample Repository Solutions | ​ | ​ | 111,593 | ​ | ​ | 105,331 | ​ | ​ | 88,922
Genomic Services | ​ | ​ | 248,296 | ​ | ​ | 250,937 | ​ | ​ | 225,175
Total revenue | ​ | $ | 665,072 | ​ | $ | 555,498 | ​ | $ | 513,703
Schedule of remaining performance obligations | Remaining Performance Obligations. Remaining performance obligations represent the transaction price of unsatisfied or partially satisfied performance obligations within contracts with an original expected contract term that is greater than one year and for which fulfillment of the contract has started as of the end of the reporting period. The aggregate amount of transaction consideration allocated to remaining performance obligations as of September 30, 2023 was $78.4 million. The following table summarizes when the Company expects to recognize the remaining performance obligations as revenue, the Company will recognize revenue associated with these performance obligations as transfer of control occurs (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | As of September 30, 2023
​ | ​ | Less than 1 Year | ​ | Greater than 1 Year | ​ | Total
Remaining performance obligations | ​ | $ | 54,159 | ​ | $ | 24,228 | ​ | $ | 78,387

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of expected timing for satisfying remaining performance obligation. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b)(1) -SubTopic 10 -Topic 606 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13 + Details
Name: | us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration